Navigating New Frontiers: Brazil’s Anvisa Updates Guidelines for Biotechnology and Radiopharmaceuticals

Read Healthcare & Pharma Guidance

Date: 28th Mar, 2025 Source: In-House Country: Brazil

Brief

On 28/03/2025, the National Health Surveillance Agency (Anvisa) issued an update regarding Anvisa publishes two new guides for biological and radio products. Two new documents were published on the AnvisaLegis portal, one updating the viral safety directive Q5A(R1) and another providing guidelines for notifying radiofármacos that are exempt from registration.

This content is restricted.

Highlights content goes here...

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Navigating New Frontiers: Brazil’s Anvisa Updates Guidelines for Biotechnology and Radiopharmaceuticals

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Navigating New Frontiers: Brazil’s Anvisa Updates Guidelines for Biotechnology and Radiopharmaceuticals

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.